- Previous Close
39.00 - Open
39.00 - Bid 39.00 x --
- Ask 39.30 x --
- Day's Range
38.15 - 40.00 - 52 Week Range
24.55 - 52.80 - Volume
691,278 - Avg. Volume
2,670,087 - Market Cap (intraday)
210.216M - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
-- - EPS (TTM)
-0.06 - Earnings Date Sep 24, 2024 - Sep 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 22, 2023
- 1y Target Est
61.00
Alliance Pharma plc acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. It provides its products under the Aloclair, Anbesol, Asthon & Parsons, Forceval, Hydromol, Kelo-Cote, MacuShield, Vamousse, Nizoral, and Amberen brand names. The company was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.
www.alliancepharmaceuticals.com292
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: APH.L
View MorePerformance Overview: APH.L
Trailing total returns as of 6/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: APH.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: APH.L
View MoreValuation Measures
Market Cap
210.22M
Enterprise Value
305.19M
Trailing P/E
--
Forward P/E
8.63
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.17
Price/Book (mrq)
0.96
Enterprise Value/Revenue
1.69
Enterprise Value/EBITDA
23.13
Financial Highlights
Profitability and Income Statement
Profit Margin
-18.34%
Return on Assets (ttm)
5.76%
Return on Equity (ttm)
-13.71%
Revenue (ttm)
180.68M
Net Income Avi to Common (ttm)
-33.14M
Diluted EPS (ttm)
-0.06
Balance Sheet and Cash Flow
Total Cash (mrq)
22.44M
Total Debt/Equity (mrq)
53.89%
Levered Free Cash Flow (ttm)
16.84M